← All trials
NCT00418028
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2005
- Primary completion
- Dec 1, 2011
- Completion date
- Dec 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 196
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Universidad Complutense de MadridLead sponsor
- H. Virgen de la SaludOverall official - principal investigator
- Hospital de PontevedraOverall official - principal investigator
- Universidad Complutense de MadridOverall official - principal investigator
- Universidad Autonoma de MadridOverall official - principal investigator
- University of SevilleOverall official - principal investigator
- University of BarcelonaOverall official - principal investigator
- University of ValenciaOverall official - principal investigator
- Centro Oncológico de GaliciaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.